Dissecting diabetes/metabolic disease mechanisms using pluripotent stem cells and genome editing tools

by Adrian Kee Keong Teo, Manoj K. Gupta, Alessandro Doria, Rohit N. Kulkarni
Published 2015-09-01

Serum resistin and glomerular filtration rate in patients with type 2 diabetes.

by Lorena Ortega Moreno, Lucia Salvemini, Christine Mendonca, Massimiliano Copetti, Concetta De Bonis, Salvatore De Cosmo, Alessandro Doria, Vincenzo Trischitta, Claudia Menzaghi
Published 2015-01-01

Serum resistin and kidney function: a family-based study in non-diabetic, untreated individuals.

by Claudia Menzaghi, Lucia Salvemini, Grazia Fini, Ryan Thompson, Davide Mangiacotti, Rosa Di Paola, Eleonora Morini, Maddalena Giorelli, Concetta De Bonis, Salvatore De Cosmo, Alessandro Doria, Vincenzo Trischitta
Published 2012-01-01

The core clock gene, Bmal1, and its downstream target, the SNARE regulatory protein secretagogin, are necessary for circadian secretion of glucagon-like peptide-1

by Andrew D. Biancolin, Alexandre Martchenko, Emilia Mitova, Patrick Gurges, Everan Michalchyshyn, Jennifer A. Chalmers, Alessandro Doria, Josyf C. Mychaleckyj, Alice E. Adriaenssens, Frank Reimann, Fiona M. Gribble, Manuel Gil-Lozano, Brian J. Cox, Patricia L. Brubaker
Published 2020-01-01

Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes.

by Claudia Menzaghi, Simonetta Bacci, Lucia Salvemini, Christine Mendonca, Giuseppe Palladino, Andrea Fontana, Concetta De Bonis, Antonella Marucci, Elizabeth Goheen, Sabrina Prudente, Eleonora Morini, Stefano Rizza, Alyssa Kanagaki, Grazia Fini, Davide Mangiacotti, Massimo Federici, Salvatore De Cosmo, Fabio Pellegrini, Alessandro Doria, Vincenzo Trischitta
Published 2014-01-01